Michael D. Burdick

1.2k total citations
20 papers, 973 citations indexed

About

Michael D. Burdick is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry. According to data from OpenAlex, Michael D. Burdick has authored 20 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Organic Chemistry. Recurrent topics in Michael D. Burdick's work include Glycosylation and Glycoproteins Research (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Michael D. Burdick is often cited by papers focused on Glycosylation and Glycoproteins Research (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Michael D. Burdick collaborates with scholars based in United States, United Kingdom and Japan. Michael D. Burdick's co-authors include Michael A. Hollingsworth, Ann Harris, Colm J. Reid, Takeshi Iwamura, Robert F. Wilson, Eberhard Mammen, J. D. Brown, Yuji Hinoda, Toshiaki Hayashi and Robert G. Schaub and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Agricultural and Food Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Michael D. Burdick

19 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael D. Burdick United States	13	515	227	209	160	146	20	973
Paula J.M. Vossebeld Netherlands	14	332 0.6×	277 1.2×	71 0.3×	205 1.3×	218 1.5×	16	849
Varsha Bhakta Canada	16	259 0.5×	59 0.3×	38 0.2×	67 0.4×	73 0.5×	60	801
J Martinéz United States	16	182 0.4×	55 0.2×	113 0.5×	45 0.3×	24 0.2×	25	997
Jan Roodt South Africa	16	124 0.2×	326 1.4×	119 0.6×	125 0.8×	20 0.1×	30	980
Guangheng Zhu Canada	12	122 0.2×	155 0.7×	104 0.5×	39 0.2×	69 0.5×	21	893
Shigeru Takamoto Japan	15	181 0.4×	95 0.4×	49 0.2×	23 0.1×	115 0.8×	46	668
Todd M. Getz United States	17	291 0.6×	160 0.7×	102 0.5×	6 0.0×	118 0.8×	32	1.2k
Elba Reyes‐Maldonado Mexico	17	232 0.5×	278 1.2×	104 0.5×	39 0.2×	152 1.0×	75	976
G Kōsaki Japan	15	206 0.4×	49 0.2×	124 0.6×	76 0.5×	188 1.3×	40	685
Suguru Akamatsu Japan	13	355 0.7×	166 0.7×	88 0.4×	75 0.5×	69 0.5×	26	631

Countries citing papers authored by Michael D. Burdick

Since Specialization

Citations

This map shows the geographic impact of Michael D. Burdick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Burdick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Burdick more than expected).

Fields of papers citing papers by Michael D. Burdick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Burdick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Burdick. The network helps show where Michael D. Burdick may publish in the future.

Co-authorship network of co-authors of Michael D. Burdick

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Burdick. A scholar is included among the top collaborators of Michael D. Burdick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Burdick. Michael D. Burdick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brinkman, Nathan, et al.. (2023). Serial virus filtration: A case study evaluating the product‐dependent impact of control strategies on process efficiency. Biotechnology Journal. 18(9). e2200599–e2200599. 1 indexed citations

Burdick, Michael D., et al.. (2016). Comparison of the Pharmacokinetics of Ketorolac Tromethamine After Continuous Subcutaneous Infusion and Repeat Intramuscular Bolus Injections in Healthy Adult Subjects. Clinical Pharmacology in Drug Development. 6(4). 343–349. 4 indexed citations

Burdick, Michael D., Dominique Pifat, Stephen R. Petteway, & Kang Cai. (2005). Clearance of Prions During Plasma Protein Manufacture. Transfusion Medicine Reviews. 20(1). 57–62. 15 indexed citations

Penalva, Luiz O. F., et al.. (2004). RNA-binding proteins to assess gene expression states of co-cultivated cells in response to tumor cells.. Molecular Cancer. 3(1). 24–24. 33 indexed citations

Kohlgraf, Karl G., Andrew J. Gawron, Michiyo Higashi, et al.. (2003). Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line.. PubMed. 63(16). 5011–20. 116 indexed citations

Silverman, Howard S., Simon Parry, Mark Sutton‐Smith, et al.. (2001). In vivo glycosylation of mucin tandem repeats. Glycobiology. 11(6). 459–471. 35 indexed citations

McDermott, Kimberly M., Paul R. Crocker, Ann Harris, et al.. (2001). Overexpression of MUC1 reconfigures the binding properties of tumor cells. International Journal of Cancer. 94(6). 783–791. 78 indexed citations

Sato, Shuji, Yuji Hinoda, Toshiaki Hayashi, et al.. (2000). Enhancement of metastatic properties of pancreatic cancer cells byMUC1 gene encoding an anti-adhesion molecule. International Journal of Cancer. 88(4). 507–518. 83 indexed citations

Sato, Shuji, Yuji Hinoda, Toshiaki Hayashi, et al.. (2000). Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti‐adhesion molecule. International Journal of Cancer. 88(4). 507–518. 4 indexed citations

10.

Beum, Paul V., Jaswant Singh, Michael D. Burdick, Michael A. Hollingsworth, & Pi-Wan Cheng. (1999). Expression of Core 2 β-1,6-N-Acetylglucosaminyltransferase in a Human Pancreatic Cancer Cell Line Results in Altered Expression of MUC1 Tumor-associated Epitopes. Journal of Biological Chemistry. 274(35). 24641–24648. 57 indexed citations

11.

Reid, Colm J., Michael D. Burdick, Michael A. Hollingsworth, & Ann Harris. (1999). CFTR expression does not influence glycosylation of an epitope-tagged MUC1 mucin in colon carcinoma cell lines. Glycobiology. 9(4). 389–398. 20 indexed citations

12.

Burdick, Michael D., Ann Harris, Colm J. Reid, Takeshi Iwamura, & Michael A. Hollingsworth. (1997). Oligosaccharides Expressed on MUC1 Produced by Pancreatic and Colon Tumor Cell Lines. Journal of Biological Chemistry. 272(39). 24198–24202. 183 indexed citations

13.

Schaub, Robert G., Ayako Yamashita, M K Bach, et al.. (1990). 1,4-Dihydronaphthoquinones as water-soluble inhibitors of 5-lipoxygenase. Prostaglandins Leukotrienes and Essential Fatty Acids. 39(4). 255–259. 2 indexed citations

14.

Yamashita, Ayako, Robert G. Schaub, Michael K. Bach, et al.. (1990). 1,4-Dihydronaphthoquinones, hydroindoloquinones, benzofurans, and benzothiophenes as inhibitors of 5-lipoxygenase. Synthesis and structure-activity studies. Journal of Medicinal Chemistry. 33(2). 775–781. 13 indexed citations

15.

Burdick, Michael D., et al.. (1988). 120 clot lysis activity of domain-deleted tPA analogs produced by a partially synthetic cassette gene. Fibrinolysis and Proteolysis. 2. 53–53. 2 indexed citations

16.

Simmons, Carol A., et al.. (1987). Heparin inhibits fibrin, but not leukocytes, in a model of deep-vein thrombosis. Journal of Surgical Research. 43(5). 468–475. 10 indexed citations

17.

Burdick, Michael D. & Robert G. Schaub. (1987). Human protein c induces anticoagulation and increased fibrinolytic activity in the cat. Thrombosis Research. 45(4). 413–419. 31 indexed citations

18.

Wilson, Robert F., et al.. (1985). Changes in antithrombin, antiplasmin, and plasminogen during and after cardiopulmonary bypass.. PubMed. 51(6). 309–13. 20 indexed citations

19.

Mammen, Eberhard, et al.. (1985). Hemostasis Changes During Cardiopulmonary Bypass Surgery. Seminars in Thrombosis and Hemostasis. 11(3). 281–292. 263 indexed citations

20.

Koshy, Kanayathu, Michael D. Burdick, & Dean W. Knuth. (1983). Multiphase photodegradation of methyl N-[[[[[(1,1-dimethylethyl)(5,5-dimethyl-2-thioxo-1,3,2-dioxaphosphorinan-2-yl)amino]thio]methylamino]carbonyl]oxy]ethanimidothioate. Journal of Agricultural and Food Chemistry. 31(3). 625–629. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact